By searching public databases, we found that EVA1 was frequently downregulated in breast cancer cell lines with mesenchymal expression profiles compared to cell lines that retained epithelial markers, such as some luminal and basal (Fig 5A). This evidence concerns the gene MPZL2 and breast cancer.